Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport vs Botox for Glabellar Lines in Chinese Subjects
NCT02450526Phase 3Completed
- Sponsor
- Ipsen
- Start
- Apr 2015
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of abobotulinumtoxinA in glabellar lines, sponsored by Ipsen. Started Apr 2015; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT02450526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450526.